Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease
Sam S. Chang, Megan E. Murphy, Lisa Malter
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 55-80
Closed Access | Times Cited: 21

Showing 21 citing articles:

Polysaccharides from an edible mushroom, Hericium erinaceus, alleviate ulcerative colitis in mice by inhibiting the NLRP3 inflammasomes and reestablish intestinal homeostasis
Hao Li, Jiaxin Feng, Chang Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131251-131251
Closed Access | Times Cited: 9
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
David Fudman, Ryan McConnell, Christina Ha, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 23, Iss. 3, pp. 454-468
Closed Access | Times Cited: 8
Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating
Jinfeng Shi, Jiahui Zhou, Bo Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
The TL1A inhibitors in IBD: what’s in the pot?
F. Lusetti, Cristina Bezzio, A. De Bernardi, et al.
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-11
Closed Access
Development and validation of a sensitive LC-MS/MS assay for determination of upadacitinib in human plasma and its application in patients with inflammatory bowel disease
Jingjing Wu, Lang Lin, Jiajia Yan, et al.
Journal of Pharmacological and Toxicological Methods (2025) Vol. 131, pp. 107581-107581
Closed Access
Efficacy of Dietary Supplementation in the Relief of Inflammatory Bowel Disease: A Systematic Review of Animal Studies
Natália Mulinari Turin de Oliveira, Carolina Silva Schiebel, Karien Sauruk da Silva, et al.
Nutrition Reviews (2025)
Closed Access
Mapping the Evolution of IBD Treatment: A Bibliometric Study on Biologics and Small Molecules
Huibo Li, Jia Wang, Yang Hu, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 312-312
Open Access
Qi-Huang decoction alleviates DSS-induced colitis with Candida albicans dysbiosis by enhancing innate immune response through Dectin-1-associated signaling
Chengcheng Liu, Yang Liu, Zixu Wang, et al.
Phytomedicine (2025) Vol. 140, pp. 156613-156613
Closed Access
Dietary succinate supplementation alleviates DSS-induced colitis via the IL-4Rα/Hif-1α Axis
Libing Liang, Buyun Dang, Xiaomei Ouyang, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114408-114408
Closed Access
Intestinal permeability disturbances: causes, diseases and therapy
Barbara Macura, Aneta Kiecka, Marian Szczepanik
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Dual Biologic Therapy Induces Remission in Refractory Crohn’s Disease with Vedolizumab and Ustekinumab
Syed Adeel Hassan, Courtney Perry, Patrick J. Carey, et al.
Crohn s & Colitis 360 (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation
Qiaoling Sun, Heng Li, Jing Lv, et al.
Cellular Immunology (2024) Vol. 401-402, pp. 104839-104839
Closed Access | Times Cited: 1
Inflammatory Bowel Disease: Immune Function, Tissue Fibrosis and Current Therapies
Jesús Cosín‐Roger
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6416-6416
Open Access | Times Cited: 1
Shaoyao decoction alleviates DSS-induced colitis by inhibiting IL-17a-mediated polarization of M1 macrophages
Shiying Wang, Linkun Cai, Yanyan Ma, et al.
Journal of Ethnopharmacology (2024), pp. 118941-118941
Open Access | Times Cited: 1
Association between depression and anxiety with the risk and flare of inflammatory bowel disease: a systematic review and meta-analysis
Guowei Gong, Cong Xu, Zhenxia Zhang, et al.
Internal and Emergency Medicine (2024)
Closed Access | Times Cited: 1
New treatments in inflammatory bowel disease � A thrilling time ahead
Fernando Gomollón
Revista Española de Enfermedades Digestivas (2024) Vol. 116
Open Access
Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics
Riccardo Rampado, Gonna Somu Naidu, Olga Karpov, et al.
Advanced Science (2024)
Open Access
Utilización de Upadacitinib en el tratamiento de la enfermedad de Crohn: reporte de dos casos clínicos
Rodrigo Quera, Andrea Córdova, Paulina Núñez, et al.
Revista de Gastroenterología del Perú (2024) Vol. 44, Iss. 2
Closed Access
MSCs-exosomes Can Promote Macrophage M2 Polarisation via Exosomal miR-21-5p through Mesenteric Injection: A Promising Way to Attenuate Murine Colitis
Wenwei Qian, Enhao Wu, Hong Chen, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 12, pp. 2045-2062
Closed Access
Remdesivir inhibits the progression of experimental colitis stimulated by dextran sodium sulfate
Hailong Li, Ying Yang, Jinhe Li, et al.
Research Square (Research Square) (2024)
Closed Access
Mycophenolate Mofetil Appears Effective For The Treatment Of Patients With Refractory Crohn’s Disease
Sam Rosenfeld, Kindra Clark‐Snustad, Kendra Kamp, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 4
Open Access
Application of Internet Hospitals in the Disease Management of Patients With Ulcerative Colitis: Retrospective Study (Preprint)
Tianzhi Yu, Wanyu Li, Yingchun Liu, et al.
(2024)
Closed Access
Page 1

Scroll to top